Phase II Study of Neoadjuvant Docetaxel, Vinorelbine, and Trastuzumab Followed by Surgery and Adjuvant Doxorubicin Plus Cyclophosphamide in Women With Human Epidermal Growth Factor Receptor 2-Overexpressing Locally Advanced Breast Cancer

S. Glück

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)402-403
Number of pages2
JournalBreast Diseases
Issue number4
StatePublished - Jan 1 2008

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this